Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
79.2M
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
18.8M
-
Shares change
-
-251K
-
Total reported value, excl. options
-
$44.8M
-
Value change
-
-$1.35M
-
Put/Call ratio
-
0.31
-
Number of buys
-
32
-
Number of sells
-
-31
-
Price
-
$2.39
Significant Holders of Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) as of Q1 2020
86 filings reported holding SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share as of Q1 2020.
Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.8M shares
of 79.2M outstanding shares and own 23.68% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4.57M shares), Bain Capital Life Sciences Investors, LLC (3.87M shares), BlackRock Inc. (1.92M shares), Artal Group S.A. (1.8M shares), BOXER CAPITAL, LLC (1.53M shares), MORGAN STANLEY (560K shares), Ikarian Capital, LLC (539K shares), STATE STREET CORP (357K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (310K shares), and D. E. Shaw & Co., Inc. (306K shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.